The procyclic stage of Trypanosoma brucei in the insect vector expresses a surface-bound trans-sialidase (TbTS) that transfers sialic acid from glycoconjugates in the environment to glycosylphosphatidylinositol-anchored proteins on its surface membrane. RNA interference against TbTS abolished transsialidase activity in procyclic cells but did not diminish sialidase activity, suggesting the presence of a separate sialidase enzyme for hydrolyzing sialic acid. A search of the T. brucei genome sequence revealed seven other putative genes encoding proteins with varying similarity to TbTS. RNA interference directed against one of these proteins, TbSA C, greatly decreased the sialidase activity but had no effect on trans-sialidase activity. The deduced amino acid sequence of TbSA C shares only 40% identity with TbTS but conserves most of the relevant residues required for catalysis. However, the sialidase has a tryptophan substitution for a tyrosine at position 170 that is crucial in binding the terminal galactose that accepts the transferred sialic acid. When this same tryptophan substitution in the sialidase was placed into the recombinant trans-sialidase, the mutant enzyme lost almost all of its trans-sialidase activity and increased its sialidase activity, further confirming that the gene and protein identified correspond to the parasite sialidase. Thus, in contrast to all other trypanosomes analyzed to date that express either a trans-sialidase or a sialidase but not both, T. brucei expresses these two enzymatic activities in two separate proteins. These results suggest that African trypanosomes could regulate the amount of critical sialic acid residues on their surface by modulating differential expression of each of these enzymes.African trypanosomes are protozoan parasites responsible for sleeping sickness in humans and a similar disease in domestic animals called nagana. Their life cycle alternates between the bloodstream of a mammalian host and the tsetse fly vector (Glossina sp.). The surface of the bloodstream form of the parasite is completely covered with 10 7 copies of a single variant surface glycoprotein (VSG) 3 bearing a glycosylphosphatidylinositol (GPI) anchor. These bloodstream trypanosomes elude the immune response of the mammalian host by periodically switching from one VSG to another immunologically distinct VSG. The bloodstream form of the parasite differentiates into the procyclic form when ingested by the insect vector. This differentiation involves a remodeling of the surface in which the VSG coat is rapidly shed and replaced with a new set of invariant GPI-anchored glycoproteins known as procyclins (1). Procyclins have an unusual GPI anchor that, unlike the GPI anchor of VSGs, is decorated with branched poly-N-acetyllactosamine repeats capped by sialic acid residues (2). Trypanosomes are unable to synthesize sialic acid, but the procyclic form of the African trypanosome Trypanosoma brucei expresses a specific enzyme, trans-sialidase (TbTS), that transfers sialic acid from sialylated glyco...